Onconetix (ONCO) Notes Payables (2023 - 2025)
Historic Notes Payables for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $160267.0.
- Onconetix's Notes Payables fell 9837.12% to $160267.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $160267.0, marking a year-over-year decrease of 9837.12%. This contributed to the annual value of $9.3 million for FY2024, which is 301.83% down from last year.
- As of Q3 2025, Onconetix's Notes Payables stood at $160267.0, which was down 9837.12% from $8.7 million recorded in Q2 2025.
- Onconetix's 5-year Notes Payables high stood at $12.9 million for Q3 2023, and its period low was $160267.0 during Q3 2025.
- Moreover, its 3-year median value for Notes Payables was $9.5 million (2023), whereas its average is $8.9 million.
- Per our database at Business Quant, Onconetix's Notes Payables skyrocketed by 1704.54% in 2024 and then tumbled by 9837.12% in 2025.
- Onconetix's Notes Payables (Quarter) stood at $9.6 million in 2023, then decreased by 3.02% to $9.3 million in 2024, then tumbled by 98.28% to $160267.0 in 2025.
- Its Notes Payables stands at $160267.0 for Q3 2025, versus $8.7 million for Q2 2025 and $9.0 million for Q1 2025.